EVMN Evommune, Inc.
Healthcare$22.87-2.89%ClosedMarket Cap: $323.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$49.83
Target (Median)
$48.50
Target Range
$40.00 - $65.00
Upside from current price: 117.9%
Rating Distribution
2 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-04-10 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.76 | $1.0M | 7 |
| Sun Dec 31 | $-3.54 | $5.8M | 3 |
| Mon Dec 31 | $-4.45 | $14.0M | 1 |
| Tue Dec 31 | $-3.02 | $165.7M | 1 |